Cargando…

Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic?

Detalles Bibliográficos
Autores principales:	Yeoh, Su-Ann, Ehrenstein, Michael R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279727/ https://www.ncbi.nlm.nih.gov/pubmed/32835250 http://dx.doi.org/10.1016/S2665-9913(20)30175-2

Ejemplares similares

Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
por: Spinelli, Francesca Romana, et al.
Publicado: (2023)

Biological tapering and sonographic flare in rheumatoid arthritis
por: Ko, Chi-Hua, et al.
Publicado: (2018)

Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors
por: Terslev, L, et al.
Publicado: (2022)

Cells of the synovium in rheumatoid arthritis. B cells
por: Mauri, Claudia, et al.
Publicado: (2007)

Prediction Aided Tapering In rheumatoid arthritis patients treated with biOlogicals (PATIO): protocol for a randomized controlled trial
por: Messelink, Marianne A., et al.
Publicado: (2022)

The Aftermath of Tapering Tocilizumab After Achieving Treatment Target in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study
por: Park, Jun Won, et al.
Publicado: (2022)

miRNAs as Biomarkers and Possible Therapeutic Strategies in Rheumatoid Arthritis
por: Kmiołek, Tomasz, et al.
Publicado: (2022)

Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study
por: Emery, Paul, et al.
Publicado: (2020)

Challenges in Applying Treat to Target Strategy in Sample of Iraqi Patients with Rheumatoid Arthritis
por: Jassim, Nizar Abdulateef, et al.
Publicado: (2021)

Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial
por: van Mulligen, Elise, et al.
Publicado: (2020)

Goals for rheumatoid arthritis: treating to target or treating to prevent?
por: Yang, Min, et al.
Publicado: (2012)

Incorporating the Treat-to-Target Concept in Rheumatoid Arthritis
por: Ruderman, Eric M., et al.
Publicado: (2012)

Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong
por: Li, Xue, et al.
Publicado: (2022)

Targeting matrix metalloproteases: A promising strategy for herbal medicines to treat rheumatoid arthritis
por: Li, Ruo-Lan, et al.
Publicado: (2022)

Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept
por: Bessette, Louis, et al.
Publicado: (2023)

Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis—a proof of principle and exploratory trial: is dose tapering practical in good responders?
por: Ibrahim, Fowzia, et al.
Publicado: (2017)

Dyslipidemia in rheumatoid arthritis: the possible mechanisms
por: Yan, Jiahui, et al.
Publicado: (2023)

Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study
por: Zhang, Wei, et al.
Publicado: (2016)

Abatacept and tocilizumab tapering in rheumatoid arthritis patients: results of SONATA—a retrospective, exploratory cohort study
por: Bouman, Chantal A M, et al.
Publicado: (2018)

What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors?
por: Bouman, Chantal A M, et al.
Publicado: (2017)

Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial
por: van Mulligen, Elise, et al.
Publicado: (2020)

Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs
por: Vodencarevic, Asmir, et al.
Publicado: (2021)

Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)
por: Adami, Giovanni, et al.
Publicado: (2023)

Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years
por: Wabe, Nasir, et al.
Publicado: (2015)

Cost-effectiveness of different treat-to-target strategies in rheumatoid arthritis: results from the DREAM registry
por: van de Laar, Celine J., et al.
Publicado: (2019)

Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis
por: Mortimer, Isabel, et al.
Publicado: (2019)

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment
por: Rech, Juergen, et al.
Publicado: (2016)

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients
por: Aletaha, Daniel, et al.
Publicado: (2017)

Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort
por: Vermeer, Marloes, et al.
Publicado: (2012)

Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea
por: Song, Jason Jungsik, et al.
Publicado: (2018)

The role of advanced MRI in the development of treat-to-target therapeutic strategies, patient stratification and phenotyping in rheumatoid arthritis
por: Mobasheri, Ali, et al.
Publicado: (2020)

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
por: Haraoui, Boulos, et al.
Publicado: (2011)

Treating rheumatoid arthritis to target: the patient version of the international recommendations
por: de Wit, M P T, et al.
Publicado: (2011)

Treating rheumatoid arthritis to target: recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2010)

Physician Adherence to Treat-to-Target and Practice Guidelines in Rheumatoid Arthritis
por: Batko, Bogdan, et al.
Publicado: (2019)

Highlights of Strategies Targeting Fibroblasts for Novel Therapies for Rheumatoid Arthritis
por: Chu, Cong-Qiu
Publicado: (2022)

Lowering Expectations: Glucocorticoid Tapering Among Veterans With Rheumatoid Arthritis Achieving Low Disease Activity on Stable Biologic Therapy
por: Wallace, Beth I., et al.
Publicado: (2023)

Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis
por: Nguyen, Dao X., et al.
Publicado: (2018)

Implementation and Evaluation of Audit and Feedback for Monitoring Treat-to-Target (T2T) Strategies in Rheumatoid Arthritis Using Performance Measures
por: Barber, Claire E. H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k4v1e5104edcc524coe5rocen0